Celgene

Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Mon, 09/26/11 - 10:29 pm
Celgene
Alexion
Soliris
Revlimid
Celgene’s Alkeran Extends Life in Eye-Cancer Patients in Study
Bloomberg
Sat, 09/24/11 - 12:45 pm
eye cancer
Celgene
Alkeran
melphalan
Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Fri, 09/23/11 - 12:03 pm
Celgene
Revlimid
Europe
EU
Multiple Myeloma
Celgene Higher on Revlimid Review Chatter
TheStreet.com
Tue, 09/20/11 - 03:27 pm
Celgene
Revlimid
10 Biotech Stocks With Falling P/E And Rising Earnings
Seeking Alpha
Mon, 08/22/11 - 06:09 pm
Celgene
Cephalon
Gilead
Life Technologies
Medifast
Dr Reddy's
Teva Pharmaceuticals
WuXi PharmaTech
United Therapeutics
Hi-Tech Pharmacal
12 Biotech Stocks the Insiders Are Buying
Motley Fool
Sat, 08/20/11 - 10:09 pm
Ligand
Halozyme
Ziopharm
OPKO Health
Theravance
Celgene
Human Genome Sciences
BioSante
Keryx
GTx
SIGA technologies
SciClone Pharmaceuticals
Big Pharma Banking on New Cancer Treatment Approach to Boost Sales
Investorplace
Mon, 08/15/11 - 12:10 pm
cancer
epigenetics
Celgene
Earnings Scorecard: Celgene Corporation
Seeking Alpha
Thu, 08/11/11 - 12:39 pm
Celgene
earnings
Good Biotech Stocks for a Bear Market
TheStreet.com
Tue, 08/9/11 - 01:27 pm
Elan
Targacept
Dendreon
Gilead Sciences
Sequenom
Vertex Pharmaceuticals
Amgen
Alexion
Biogen Idec
Celgene
Revlimid side effects linked to protein in study
Reuters, UK
Tue, 08/9/11 - 10:10 am
Multiple Myeloma
Celgene
Revlimid
Adolor: Key Catalysts Are Looming in Q3, Buy Reiterated
Seeking Alpha
Tue, 08/2/11 - 12:30 pm
Adolor
Celgene
GSK
Jazz Pharmaceuticals
Celgene's Earnings Should Double by 2015
Seeking Alpha
Mon, 08/1/11 - 10:23 am
Celgene
earnings
Four Drug Stocks To Watch On Thursday
Investopedia
Wed, 07/27/11 - 01:21 pm
Celgene
Bristol-Myers Squibb
United Therapeutics
Sanofi
Celgene’s Blood-Cancer Treatment Backed by U.K. Cost Agency
Bloomberg
Tue, 07/26/11 - 09:57 pm
UK
Celgene
thalidomide
Multiple Myeloma
The Next Big Thing In Biotech: Celgene
The Street
Sat, 07/23/11 - 04:27 pm
Celgene
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
Cramer Interviews Celgene CEO Hugin
CNBC
Fri, 07/1/11 - 09:53 am
Celgene
Pharma CEOs
Bob Hugin
Label Expansion for CELG's Istodax
Yahoo/Zacks.com
Tue, 06/21/11 - 10:32 am
Istodax
Celgene
cancer
J&J Fails to Win Appeal of U.K. Backing of Rival’s Thalidomide
Bloomberg
Thu, 06/16/11 - 10:17 pm
JNJ
thalidomide
Celgene
Velcade

Pages